Related Experiment Video
Updated: Jul 9, 2025

Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia
Published on: September 22, 2020
Revascularization with BYCROSS atherectomy device- protocol of a prospective multicenter observational study
Dominik Liebetrau1, Joerg Teßarek2, Florian Elger3
1Vascular Surgery, Medical Faculty, University of Augsburg, Stenglinstrasse 2, 86156, Augsburg, Germany. dominik.liebetrau@uk-augsburg.de.
The BYCROSS™ atherectomy system offers a novel, minimally invasive treatment for peripheral arterial disease (PAD), including complex calcified lesions. This study evaluates its safety and effectiveness in patients with severe PAD.
Area of Science:
- Vascular Surgery
- Interventional Cardiology
- Medical Device Technology
Background:
- Peripheral arterial disease (PAD) often involves complex, calcified lesions that are challenging to treat.
- Traditional treatments for such lesions may include invasive bypass surgery.
- The BYCROSS™ atherectomy system presents a novel, minimally invasive approach.
Purpose of the Study:
- To collect clinical data on the safety and performance of the BYCROSS™ atherectomy system.
- To evaluate the device's efficacy in treating severely stenotic or occluded peripheral arteries.
- To assess the device's potential as an alternative to bypass surgery for complex PAD cases.
Main Methods:
- An investigator-initiated, national, prospective, multicenter observational study.
- Sixty patients with PAD (stenosis >80% or occlusion) in vessels below the aortic bifurcation were recruited across three vascular surgery centers.
- Primary endpoints included procedural success and freedom from device-related serious adverse events (SADEs).
Main Results:
- Procedural success was defined as successful passage of the occlusion with the BYCROSS device.
- Safety outcomes focused on freedom from device-related serious adverse events (SADEs).
- Secondary endpoints assessed patency rates, Rutherford classification changes, and amputation rates at 3 and 12 months.
Conclusions:
- The BYCROSS™ atherectomy system shows potential as a novel device for minimally invasive treatment of complex, calcified PAD lesions.
- This study contributes to demonstrating the efficacy and safety of the BYCROSS™ device for PAD treatment.
- The findings may support the use of BYCROSS™ as an alternative to bypass surgery for specific patient populations.
More Related Videos
13:48Reduction of Radiation Exposure during Endovascular Treatment of Peripheral Arterial Disease Combining Fiber Optic RealShape Technology and Intravascular Ultrasound
Published on: April 21, 2023
04:30A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis
Published on: May 14, 2013